Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Evaluation of ChatGPT-5 responses to patient-centered questions on stromal vascular fraction for knee osteoarthritis: fair to good quality and content.

Mercan N., Eravsar E., Ergi̇n M., Çatal T., Çi̇ftci̇ S., Akkaya M.

Prospective Study on Knee Osteoarthritis, Osteoarthritis, published in BMC Musculoskelet Disord (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
BMC Musculoskelet Disord (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41832448
PMCID
PMC13104398
DOI
10.1186/s12891-026-09731-y

Abstract (original English)

BACKGROUND: The global burden of symptomatic knee osteoarthritis (KOA) continues to grow, driving clinical interest in biological treatment options. Stromal vascular fraction (SVF), derived from adipose tissue, has gained attention as a potential therapy for KOA. As patients increasingly utilize large language models (LLMs) like ChatGPT for health information, this study aimed to evaluate the patient-information quality and readability of AI-generated responses to a curated set of patient-centered questions on SVF therapy for KOA. METHODS: Thirty patient-centered questions were developed through literature review by two experts and then posed to ChatGPT-5 after asking it to answer from an orthopaedic specialist perspective. Responses from ChatGPT-5 were evaluated by four orthopaedic specialists using three quality instruments: DISCERN, NLAT-AI (assessing five domains: Accuracy, Safety, Appropriateness, Actionability, and Effectiveness), and the Mika et al. scoring system. Readability was assessed using five standard metrics. RESULTS: Mean scores were as follows: DISCERN 44.61 ± 4.94 (Fair); for NLAT-AI domains, Accuracy 3.92 ± 0.50 (Good), Safety 3.23 ± 0.78 (Fair), Appropriateness 4.14 ± 0.32 (Good), Actionability 3.20 ± 0.67 (Fair), and Effectiveness 4.46 ± 0.35 (Excellent); NLAT-AI (Total/ sum of five domains) 18.95 ± 1.93 (Good); Mika et al. 2.45 ± 0.49 (Fair). Readability

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansOsteoarthritis, KneeLarge Language ModelsPatient Education as TopicStromal CellsGenerative Artificial IntelligenceComprehensionFemaleSurveys and QuestionnairesPatient-Centered Care

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research